Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.